Alvotech (ALVO)
USD 7.96
(-6.35%)
USD 7.96
(-6.35%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 950.09 Million USD | 14.68% |
| 2022 | 828.44 Million USD | 38.54% |
| 2021 | 597.97 Million USD | 26.04% |
| 2020 | 474.42 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.06 Billion USD | 0.74% |
| 2024 Q1 | 1.06 Billion USD | 11.64% |
| 2023 Q2 | 910.66 Million USD | 1.7% |
| 2023 FY | 950.09 Million USD | 14.68% |
| 2023 Q4 | 950.09 Million USD | -0.91% |
| 2023 Q3 | 958.81 Million USD | 5.29% |
| 2023 Q1 | 895.46 Million USD | 8.09% |
| 2022 Q1 | 250.69 Million USD | -58.08% |
| 2022 FY | 828.44 Million USD | 38.54% |
| 2022 Q4 | 828.44 Million USD | 21.27% |
| 2022 Q3 | 683.12 Million USD | -11.8% |
| 2022 Q2 | 774.49 Million USD | 208.94% |
| 2021 Q3 | 251.07 Million USD | -0.04% |
| 2021 Q4 | 597.97 Million USD | 138.16% |
| 2021 Q2 | 251.18 Million USD | -0.07% |
| 2021 Q1 | 251.36 Million USD | -0.07% |
| 2021 FY | 597.97 Million USD | 26.04% |
| 2020 Q2 | 118.6 Million USD | 0.0% |
| 2020 Q1 | 118.6 Million USD | 0.0% |
| 2020 Q4 | 251.53 Million USD | 112.08% |
| 2020 Q3 | 118.6 Million USD | 0.0% |
| 2020 FY | 474.42 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Cosmos Health Inc. | 66.29 Million USD | -1333.112% |
| Safety Shot Inc | 12.7 Million USD | -7375.62% |
| Bright Green Corporation | 17.4 Million USD | -5359.331% |
| Embecta Corp. | 1.21 Billion USD | 21.765% |
| ANI Pharmaceuticals, Inc. | 904.42 Million USD | -5.049% |
| Aquestive Therapeutics, Inc. | 57.41 Million USD | -1554.69% |
| Collegium Pharmaceutical, Inc. | 1.14 Billion USD | 16.9% |
| Dynavax Technologies Corporation | 997.09 Million USD | 4.714% |
| Esperion Therapeutics, Inc. | 205.79 Million USD | -361.666% |
| Intra-Cellular Therapies, Inc. | 728.29 Million USD | -30.454% |
| Pacira BioSciences, Inc. | 1.57 Billion USD | 39.653% |
| PainReform Ltd. | 9.93 Million USD | -9467.875% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | -3374.207% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | -3374.207% |
| SCYNEXIS, Inc. | 128.41 Million USD | -639.876% |
| China SXT Pharmaceuticals, Inc. | 23.12 Million USD | -4008.132% |
| Journey Medical Corporation | 76.84 Million USD | -1136.308% |
| Alpha Teknova, Inc. | 128.58 Million USD | -638.869% |
| Procaps Group, S.A. | 460.18 Million USD | -106.457% |
| Theratechnologies Inc. | 77.76 Million USD | -1121.682% |
| Harrow Health, Inc. | 311.75 Million USD | -204.755% |
| Sonoma Pharmaceuticals, Inc. | 14.89 Million USD | -6279.44% |
| Biofrontera Inc. | 27.93 Million USD | -3301.439% |
| DURECT Corporation | 45.18 Million USD | -2002.481% |
| Supernus Pharmaceuticals, Inc. | 1.4 Billion USD | 32.569% |
| Cronos Group Inc. | 1.13 Billion USD | 16.236% |
| OptiNose, Inc. | 107.72 Million USD | -781.926% |
| Ironwood Pharmaceuticals, Inc. | 471.07 Million USD | -101.686% |
| Kala Pharmaceuticals, Inc. | 55.94 Million USD | -1598.136% |
| RedHill Biopharma Ltd. | 23.04 Million USD | -4022.378% |
| Organogenesis Holdings Inc. | 460.02 Million USD | -106.53% |
| Guardion Health Sciences, Inc. | 11.91 Million USD | -7871.773% |
| Cumberland Pharmaceuticals Inc. | 81.77 Million USD | -1061.819% |
| Radius Health, Inc. | 1.71 Billion USD | 44.632% |
| Universe Pharmaceuticals INC | 53.28 Million USD | -1682.967% |
| ProPhase Labs, Inc. | 91.92 Million USD | -933.527% |
| Phibro Animal Health Corporation | 982.18 Million USD | 3.268% |
| Procaps Group S.A. | 460.18 Million USD | -106.457% |
| TherapeuticsMD, Inc. | 43.3 Million USD | -2093.747% |
| Viatris Inc. | 47.68 Billion USD | 98.008% |
| Rockwell Medical, Inc. | 52.17 Million USD | -1721.038% |
| Aytu BioPharma, Inc. | 118.09 Million USD | -704.513% |
| SIGA Technologies, Inc. | 254.83 Million USD | -272.824% |
| Tilray Brands, Inc. | 4.33 Billion USD | 78.085% |
| Lifecore Biomedical, Inc. | 273.7 Million USD | -247.126% |
| Shineco, Inc. | 84.17 Million USD | -1028.649% |
| PetIQ, Inc. | 868.22 Million USD | -9.429% |
| Regencell Bioscience Holdings Limited | 8.43 Million USD | -11159.377% |
| Incannex Healthcare Limited | 17.04 Million USD | -5473.356% |
| Neurocrine Biosciences, Inc. | 3.25 Billion USD | 70.779% |
| Alimera Sciences, Inc. | 153.52 Million USD | -518.854% |
| Silver Spike Investment Corp. | 88.57 Million USD | -972.624% |
| Assertio Holdings, Inc. | 286.41 Million USD | -231.713% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.95 Million USD | -15863.242% |
| Petros Pharmaceuticals, Inc. | 33.79 Million USD | -2711.267% |
| Clever Leaves Holdings Inc. | 31.24 Million USD | -2940.969% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -7071.823% |
| Avadel Pharmaceuticals plc | 261.12 Million USD | -263.844% |
| Hempacco Co., Inc. | 18.04 Million USD | -5165.675% |
| Talphera, Inc. | 20.39 Million USD | -4558.446% |
| Alvotech | 950.09 Million USD | 0.0% |
| Eagle Pharmaceuticals, Inc. | 406.16 Million USD | -133.92% |
| Lantheus Holdings, Inc. | 1.65 Billion USD | 42.459% |
| Currenc Group, Inc. | 141.49 Million USD | -571.487% |
| Kamada Ltd. | 351.96 Million USD | -169.935% |
| Indivior PLC | 1.95 Billion USD | 51.308% |
| Evoke Pharma, Inc. | 7.06 Million USD | -13341.095% |
| Flora Growth Corp. | 23.62 Million USD | -3921.375% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -7071.823% |
| Evolus, Inc. | 188.99 Million USD | -402.698% |
| HUTCHMED (China) Limited | 1.27 Billion USD | 25.761% |
| Amphastar Pharmaceuticals, Inc. | 1.51 Billion USD | 37.201% |
| Akanda Corp. | 8.83 Million USD | -10647.633% |